Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria
18 juil. 2024 11h35 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
01 juil. 2024 16h31 HE
|
HOOKIPA Pharma Inc.
Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (Gilead), to be evaluated as a potential component of a curative regimen for human immunodeficiency...
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27 juin 2024 09h00 HE
|
bioLytical Laboratories Inc.
bioLytical helps boost testing with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support national testing efforts
Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
29 mai 2024 06h30 HE
|
Casey House
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign,...
National Implementation of Supportive Housing Initiative to Close the Gap on HIV-Related Inequities Outlined in the National HIV/AIDS Strategy
07 mai 2024 09h00 HE
|
Corporation for Supportive Housing
Boston, Massachusetts, May 07, 2024 (GLOBE NEWSWIRE) -- The Center for Innovation in Social Work and Health (CISWH) at the Boston University School of Social Work (BUSSW) and CSH (Corporation for...
Immunocore presented two posters at CROI 2024
05 mars 2024 16h30 HE
|
Immunocore Holdings Limited
Immunocore presented two posters at CROI 2024 Preclinical data highlights importance of TCR biology in development of new HIV treatments (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. &...
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
28 déc. 2023 21h49 HE
|
Novotech
Novotech today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.